OTCMKTS:VBIO

Vitality Biopharma News Headlines

$0.22
+0.05 (+29.41 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.17
Now: $0.22
$0.22
50-Day Range
$0.13
MA: $0.20
$0.26
52-Week Range
$0.03
Now: $0.22
$0.55
Volume11,706 shs
Average Volume51,077 shs
Market Capitalization$11.13 million
P/E RatioN/A
Dividend YieldN/A
Beta3.26

Headlines

Vitality Biopharma (OTCMKTS VBIO) News Headlines Today

SourceHeadline
Vitality Biopharma (OTCMKTS:VBIO) Shares Cross Above Two Hundred Day Moving Average of $0.15Vitality Biopharma (OTCMKTS:VBIO) Shares Cross Above Two Hundred Day Moving Average of $0.15
americanbankingnews.com - April 6 at 1:58 AM
Vitality Biopharma, Inc. (OTCMKTS:VBIO) Short Interest Up 260.0% in MarchVitality Biopharma, Inc. (OTCMKTS:VBIO) Short Interest Up 260.0% in March
americanbankingnews.com - March 28 at 1:32 AM
Vitality Biopharma (OTCMKTS:VBIO) Stock Price Crosses Above Two Hundred Day Moving Average of $0.14Vitality Biopharma (OTCMKTS:VBIO) Stock Price Crosses Above Two Hundred Day Moving Average of $0.14
americanbankingnews.com - March 27 at 2:02 AM
Vitality Biopharma (OTCMKTS:VBIO) Share Price Crosses Above 200 Day Moving Average of $0.14Vitality Biopharma (OTCMKTS:VBIO) Share Price Crosses Above 200 Day Moving Average of $0.14
americanbankingnews.com - March 19 at 1:01 AM
Vitality Biopharma IncVitality Biopharma Inc
bloomberg.com - October 15 at 9:45 PM
Vitality Biopharma Hires Investment Bank To Explore M&A, Asset Sale OpportunitiesVitality Biopharma Hires Investment Bank To Explore M&A, Asset Sale Opportunities
benzinga.com - September 25 at 5:50 PM
Vitality Biopharma Retains DelMorgan & Co. to Explore Strategic AlternativesVitality Biopharma Retains DelMorgan & Co. to Explore Strategic Alternatives
markets.businessinsider.com - September 25 at 12:49 PM
Cannabis Stock Gainers And Losers From September 1, 2020Cannabis Stock Gainers And Losers From September 1, 2020
msn.com - September 3 at 12:04 AM
Vitality Biopharma Receives $8.5 Million Common Stock FinancingVitality Biopharma Receives $8.5 Million Common Stock Financing
www.bloomberg.com - July 23 at 10:40 PM
Vitality Biopharma, Inc. (VBIO)Vitality Biopharma, Inc. (VBIO)
finance.yahoo.com - July 4 at 11:14 PM
Vitality Biopharma Board UpdateVitality Biopharma Board Update
finance.yahoo.com - April 27 at 7:28 PM
Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THCVitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC
www.bloomberg.com - March 20 at 7:33 AM
Vitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets WorldwideVitality Biopharma Files Intellectual Property in All Major Pharmaceutical Markets Worldwide
www.bloomberg.com - March 18 at 12:52 AM
Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40Vitality Biopharma Receives Updated SeeThruEquity Price Target of $2.40
www.bloomberg.com - January 1 at 8:20 PM
Vitality Biopharma Inc.Vitality Biopharma Inc.
www.barrons.com - October 11 at 10:42 PM
Vitality Biopharma Welcomes New Executive Management TeamVitality Biopharma Welcomes New Executive Management Team
finance.yahoo.com - May 14 at 10:12 AM
Vitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of DirectorsVitality Biopharma Co-Founder Dr. Avtar Dhillon Resigns from Board of Directors
finance.yahoo.com - April 25 at 5:44 PM
Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board - GlobeNewswireVitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board - GlobeNewswire
globenewswire.com - January 25 at 9:44 AM
Vitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to BoardVitality Biopharma Appoints Former Ohio Governor Richard F. Celeste to Board
finance.yahoo.com - January 24 at 5:11 PM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.